Abstract:PURPOSE: Matrix metalloproteinase (MMP)-2 and MMP-9 are considered to play an important role in the metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) and tissue inhibitor of metalloproteinase 2 (TIMP-2) are essential factors for the activation of pro-MMP-2. There are some reports about expressions of MMP family in relationship to clinical features of head and neck squamous cell carcinoma (SCC), but the results were not uniform and the prognostic value of their expressions remains unclear.EXPERIMENTAL DESIGN: The study group consisted of 53 Japanese patients with oral SCC of early stage (T(1-2)N(0)M(0)). Expressions of MMP-2, MMP-9, MT1-MMP, and TIMP-2 were examined using immunohistological methods on the sections of tumor biopsy samples. The intensity of MMP expression was categorized into four grades (score 0-3) by semiquantitative analysis using a computer with NIH image, and correlation between this grade and clinical aspects such as tumor recurrence, metastasis, and prognosis were examined.RESULTS: The expression score of MMP-2 correlated with that of MMP-9 (r = 0.291; P = 0.036), MT1-MMP (r = 0.286; P = 0.039), and TIMP-2 (r = 0.257; P = 0.050). Patients who developed regional lymph node and/or distant metastasis showed significantly higher scores in the expressions of MMP-9 and TIMP-2 than patients without any tumor metastases (P = 0.036 and P = 0.043, respectively). Kaplan-Meier analyses as well as univariate analyses using the Cox proportional hazards model showed that expression of MMP-9 (P = 0.0143 and P = 0.0418, respectively) and marked expression of TIMP-2 (P < 0.0001 and P = 0.0004, respectively) correlated with worse-cause-specific survival. Multivariate analysis confirmed that marked expression of TIMP-2 was the only independent factor for cause-specific death (hazard ratio, 7.543; confidence interval, 1.693-33.610; P = 0.0080).CONCLUSIONS: Expressions of MMP-9 and TIMP-2 have predictive value for tumor metastases and cause-specific survival. High expression of TIMP-2 is the most independent factor for worse prognosis in early-stage oral SCC.

Expression of MMP-2 and MMP-9 and FHIT in Oral Squamous Cell Carcinoma

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Expression of MMP-1,MMP-2,uPA in oral squamous cell carcinoma

Expression of extracellular matrix metalloproteinase inducer CD147 and MMP-9 in hepatocellular carcinoma and its clinical significance

Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis

Relationship between expression of MMP-9,FAK and lymphnode metastasis of tongue squamous cell carcinoma

Correlation of Matrix Metalloproteinase-2, −9, Tissue Inhibitor-1 of Matrix Metalloproteinase and CD44 Variant 6 in Head and Neck Cancer Metastasis

COX-2, MMP-7 Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma

Expression and Significance of E-cd and MMP-2 in Oral Squamous Cell Carcinoma

Relationship between expression of MMP-2 and cervical lymph node micrometastasis in oral squamous cell carcinoma

Expression of MMP-9 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Expression of MMP-2, MMP-9, TIMP-1, and TIMP-2 in Human Esophageal Squamous Cell Carcinoma Tissue

Expression and Implication of Focal Adhesion Kinase and MMP9 in Squamous Cell Carcinoma of the Larynx

Immunoexpression of Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 in the Metastasis of Squamous Cell Carcinoma of the Human Tongue

EXPRESSION OF MATRIX METALLOPROTEINASE-2 IN LUNG SQUAMOUS CELL CARCINOMA

Expression of MMP-9 Mrna in Human Hepatocellular Carcinoma

Clinical Significance of the Expression of Osteopontin and MMP-9 in Breast Cancer

The Role of Matrix Metalloproteinase Expression in Lung Cancer Metastasis

Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma